Search for: "Abbott Laboratories v. Sandoz, Inc."
Results 41 - 60
of 69
Sorted by Relevance
|
Sort by Date
27 May 2010, 3:20 am
Sandoz Inc. [read post]
20 Jan 2011, 12:50 pm
July 3, 2003); Wyeth-Ayerst Laboratories Co. v. [read post]
13 May 2010, 4:58 pm
Sandoz, Inc. [read post]
4 Jun 2009, 5:30 am
One would have expected that these reforms to have brought the...Patent SOS: Inequitable Conduct Reform ASAPNot long ago the United States Court of Appeals for the Federal Circuit issued a decision in Abbott Laboratories v. [read post]
25 May 2009, 5:20 pm
Todd Dickinson’s comments at Bio Conference (IAM) The Charles Rivers Ventures connection – CRV stakes in RPX Corp, Thinkfire and Intellectual Ventures (IAM) Obama Administration tackling patent backlog (IP Watchdog) Patent examiners told to issue patents (IP Watchdog) More funding needed for patent granting authority (IP Watchdog) Short note on patentability of product-by-process claims – Newman J’s opinion in 1985 case In re Thorpe: Abbott v… [read post]
8 Mar 2011, 1:23 pm
Cir. 2009) (en banc in part) Abbott Laboratories v. [read post]
15 Sep 2011, 5:00 am
Abbott Laboratories, 447 F.3d 861, 867 [read post]
21 Feb 2014, 8:53 am
Sandoz-Wander, Inc., 464 N.E.2d 1105, 1111 (Ill. [read post]
7 Apr 2010, 4:30 am
Sandoz Pharmaceuticals GmbH et al (EPLAW) Prilosec (Omeprazole) – US: AstraZeneca ordered to pay attorney’s fees for ‘baseless’ suit to protect Prilosec OTC: AstraZeneca AB et al. v. [read post]
24 Aug 2011, 12:33 am
Novartis (IPBiz) Simcor (Niacin, Simvastatin) – US: Abbott Laboratories files patent infringement complaint against Teva in response to Para IV challenge (Patent Docs) Vanos (Fluocinonide) – US: Medicis and Nycomed settle Vanos patent dispute (Patent Docs) Viagra (Sildenafil) – US: Pfizer’s patent on Viagra upheld by the EDVA: Pfizer v Teva (Rocket Docket IP Blog) (Patent Docs) (The IP Factor) [read post]
14 Dec 2009, 4:38 pm
Sandoz, Inc. [read post]
2 Apr 2024, 8:44 am
Abbott Labs. v. [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
12 Jun 2014, 8:48 pm
Sandoz, Inc., 678 F.3d 1280, 1293 (Fed. [read post]
24 Feb 2010, 2:11 am
Co. v Doll (Filewrapper) US: District Court Massachusetts denies bid for bench trial in RNAi patent suit: Max-Planck-Gesellschaft v Whitehead Institute for Biomedical Research (Patent Docs) US: Court of Appeal for the Ninth Circuit: Federal jurisdiction found in Neuralstem v Reneuron (Patent Docs) US: District Court New Jersey: Disqualification of counsel in patent case requires ‘factual analysis’, not ‘automatic disqualification rule’: Wyeth et al… [read post]
24 Feb 2010, 2:11 am
Co. v Doll (Filewrapper) US: District Court Massachusetts denies bid for bench trial in RNAi patent suit: Max-Planck-Gesellschaft v Whitehead Institute for Biomedical Research (Patent Docs) US: Court of Appeal for the Ninth Circuit: Federal jurisdiction found in Neuralstem v Reneuron (Patent Docs) US: District Court New Jersey: Disqualification of counsel in patent case requires ‘factual analysis’, not ‘automatic disqualification rule’: Wyeth et al… [read post]
15 Jan 2008, 3:06 am
filed 03/22/07 1:07-cv-01721 Abbott Laboratories et al v. [read post]
28 Dec 2012, 1:57 pm
Centocor, Inc. v. [read post]
20 Jul 2011, 4:04 am
: Supreme Court hearing Human Genome Sciences Inc v Eli Lilly and Company (IPKat) Nexium (Esomeprazole) – UK: EWHC: Ranbaxy wins declaration of non-infringement: Ranbaxy v AstraZeneca (IPKat) Olanzapine – Spain: Supreme Court hands down landmark judgment on doctrine of equivalents and TRIPS (Kluwer Patent Blog) OxyContin (Oxycodone) – US: Purdue files patent infringement suit against Sandoz in response to Para IV certification (Patent Docs)… [read post]
11 Jan 2008, 9:00 am
: (IP Spotlight)PharmaIndia: Trade mark assignment under scrutiny in a case of deceptive similarity - Doctor Morepen Limited v Yash Pharma Laboratories Limited: (Mondaq),Arrow v Merck - An early route to market for generics? [read post]
